AVIR
Atea Pharmaceuticals Inc
NASDAQ: AVIR · HEALTHCARE · BIOTECHNOLOGY
$5.50
-3.85% today
Updated 2026-06-05
Market cap
$341.72M
P/E ratio
—
P/S ratio
1.55x
EPS (TTM)
$-2.11
Dividend yield
—
52W range
$3 – $6
Volume
0.3M
Atea Pharmaceuticals Inc (AVIR) Insider transactions
Net insider activity
Net buying (2,491,685 shares)
Buy transactions
59
Sell transactions
41
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-11 | CORCORAN, ANDREA | See Remarks | Buy | 60,000 | — | — |
| 2026-03-11 | CORCORAN, ANDREA | See Remarks | Buy | 60,000 | $1.24 | $74400.00 |
| 2026-02-03 | SOMMADOSSI, JEAN-PIERRE | Director, President, CEO, and Chairman | Sale | 300,000 | — | — |
| 2026-02-03 | SOMMADOSSI, JEAN-PIERRE | Director, President, CEO, and Chairman | Buy | 300,000 | $1.24 | $372000.00 |
| 2026-01-31 | VAVRICKA, JOHN | Chief Commercial Officer | Buy | 119,520 | — | — |
| 2026-01-31 | VAVRICKA, JOHN | Chief Commercial Officer | Sale | 33,333 | — | — |
| 2026-01-31 | VAVRICKA, JOHN | Chief Commercial Officer | Sale | 8,750 | — | — |
| 2026-01-31 | VAVRICKA, JOHN | Chief Commercial Officer | Buy | 42,083 | — | — |
| 2026-01-31 | VAVRICKA, JOHN | Chief Commercial Officer | Sale | 11,570 | $4.24 | $49056.80 |
| 2026-01-31 | SOMMADOSSI, JEAN-PIERRE | Director, President, CEO, and Chairman | Sale | 173,466 | — | — |
| 2026-01-31 | SOMMADOSSI, JEAN-PIERRE | Director, President, CEO, and Chairman | Sale | 99,517 | — | — |
| 2026-01-31 | SOMMADOSSI, JEAN-PIERRE | Director, President, CEO, and Chairman | Buy | 272,983 | — | — |
| 2026-01-31 | SOMMADOSSI, JEAN-PIERRE | Director, President, CEO, and Chairman | Sale | 106,093 | $4.24 | $449834.32 |
| 2026-01-31 | HORGA, MARIA ARANTXA | Chief Medical Officer | Buy | 173,500 | — | — |
| 2026-01-31 | HORGA, MARIA ARANTXA | Chief Medical Officer | Sale | 41,533 | — | — |
| 2026-01-31 | HORGA, MARIA ARANTXA | Chief Medical Officer | Sale | 9,750 | — | — |
| 2026-01-31 | HORGA, MARIA ARANTXA | Chief Medical Officer | Buy | 51,283 | — | — |
| 2026-01-31 | HORGA, MARIA ARANTXA | Chief Medical Officer | Sale | 16,073 | $4.24 | $68149.52 |
| 2026-01-31 | HAMMOND, JANET MJ | Chief Development Officer | Buy | 177,000 | — | — |
| 2026-01-31 | HAMMOND, JANET MJ | Chief Development Officer | Sale | 46,800 | — | — |
| 2026-01-31 | HAMMOND, JANET MJ | Chief Development Officer | Sale | 11,250 | — | — |
| 2026-01-31 | HAMMOND, JANET MJ | Chief Development Officer | Buy | 58,050 | — | — |
| 2026-01-31 | HAMMOND, JANET MJ | Chief Development Officer | Sale | 14,136 | $4.24 | $59936.64 |
| 2026-01-31 | FOSTER, WAYNE | EVP, Chief Accounting Officer | Buy | 108,000 | — | — |
| 2026-01-31 | FOSTER, WAYNE | EVP, Chief Accounting Officer | Sale | 33,333 | — | — |
| 2026-01-31 | FOSTER, WAYNE | EVP, Chief Accounting Officer | Sale | 8,000 | — | — |
| 2026-01-31 | FOSTER, WAYNE | EVP, Chief Accounting Officer | Buy | 41,333 | — | — |
| 2026-01-31 | FOSTER, WAYNE | EVP, Chief Accounting Officer | Sale | 12,132 | $4.24 | $51439.68 |
| 2026-01-31 | CORCORAN, ANDREA | See Remarks | Buy | 180,000 | — | — |
| 2026-01-31 | CORCORAN, ANDREA | See Remarks | Sale | 44,366 | — | — |
| 2026-01-31 | CORCORAN, ANDREA | See Remarks | Sale | 10,500 | — | — |
| 2026-01-31 | CORCORAN, ANDREA | See Remarks | Buy | 54,866 | — | — |
| 2026-01-31 | CORCORAN, ANDREA | See Remarks | Sale | 16,104 | $4.24 | $68280.96 |
| 2025-06-20 | POLSKY, BRUCE | Director | Buy | 41,200 | — | — |
| 2025-06-20 | POLSKY, BRUCE | Director | Sale | 29,600 | — | — |
| 2025-06-20 | POLSKY, BRUCE | Director | Buy | 29,600 | — | — |
| 2025-06-20 | MURPHY, POLLY A. | Director | Buy | 41,200 | — | — |
| 2025-06-20 | MURPHY, POLLY A. | Director | Sale | 29,600 | — | — |
| 2025-06-20 | MURPHY, POLLY A. | Director | Buy | 29,600 | — | — |
| 2025-06-20 | LUCIDI, BRUNO | Director | Buy | 41,200 | — | — |
| 2025-06-20 | LUCIDI, BRUNO | Director | Sale | 29,600 | — | — |
| 2025-06-20 | LUCIDI, BRUNO | Director | Buy | 29,600 | — | — |
| 2025-06-20 | DUNCAN, BARBARA GAYLE | Director | Buy | 41,200 | — | — |
| 2025-06-20 | DUNCAN, BARBARA GAYLE | Director | Sale | 29,600 | — | — |
| 2025-06-20 | DUNCAN, BARBARA GAYLE | Director | Buy | 29,600 | — | — |
| 2025-06-20 | BERMAN, HOWARD | Director | Buy | 164,800 | — | — |
| 2025-06-20 | BERGER, FRANKLIN M | Director | Buy | 41,200 | — | — |
| 2025-06-20 | BERGER, FRANKLIN M | Director | Sale | 29,600 | — | — |
| 2025-06-20 | BERGER, FRANKLIN M | Director | Buy | 29,600 | — | — |
| 2025-06-20 | ADAMS, JEROME M. | Director | Buy | 41,200 | — | — |
| 2025-06-20 | ADAMS, JEROME M. | Director | Sale | 29,600 | — | — |
| 2025-06-20 | ADAMS, JEROME M. | Director | Buy | 29,600 | — | — |
| 2025-02-20 | KIRSCH, ARTHUR S | Director | Buy | 164,800 | — | — |
| 2025-01-31 | VAVRICKA, JOHN | Chief Commercial Officer | Buy | 132,800 | — | — |
| 2025-01-31 | VAVRICKA, JOHN | Chief Commercial Officer | Sale | 33,333 | — | — |
| 2025-01-31 | VAVRICKA, JOHN | Chief Commercial Officer | Buy | 8,750 | — | — |
| 2025-01-31 | VAVRICKA, JOHN | Chief Commercial Officer | Buy | 33,333 | — | — |
| 2025-01-31 | VAVRICKA, JOHN | Chief Commercial Officer | Sale | 11,517 | $3.06 | $35242.02 |
| 2025-01-31 | VAVRICKA, JOHN | Chief Commercial Officer | Buy | 8,750 | — | — |
| 2025-01-31 | SOMMADOSSI, JEAN-PIERRE | Director, President, CEO, and Chairman | Buy | 440,000 | — | — |
| 2025-01-31 | SOMMADOSSI, JEAN-PIERRE | Director, President, CEO, and Chairman | Sale | 173,467 | — | — |
| 2025-01-31 | SOMMADOSSI, JEAN-PIERRE | Director, President, CEO, and Chairman | Buy | 99,518 | — | — |
| 2025-01-31 | SOMMADOSSI, JEAN-PIERRE | Director, President, CEO, and Chairman | Buy | 173,467 | — | — |
| 2025-01-31 | SOMMADOSSI, JEAN-PIERRE | Director, President, CEO, and Chairman | Buy | 99,517 | — | — |
| 2025-01-31 | SOMMADOSSI, JEAN-PIERRE | Director, President, CEO, and Chairman | Sale | 88,601 | $3.06 | $271119.06 |
| 2025-01-31 | HORGA, MARIA ARANTXA | Chief Medical Officer | Buy | 192,800 | — | — |
| 2025-01-31 | HORGA, MARIA ARANTXA | Chief Medical Officer | Sale | 41,533 | — | — |
| 2025-01-31 | HORGA, MARIA ARANTXA | Chief Medical Officer | Buy | 9,750 | — | — |
| 2025-01-31 | HORGA, MARIA ARANTXA | Chief Medical Officer | Buy | 41,533 | — | — |
| 2025-01-31 | HORGA, MARIA ARANTXA | Chief Medical Officer | Sale | 16,071 | $3.06 | $49177.26 |
| 2025-01-31 | HORGA, MARIA ARANTXA | Chief Medical Officer | Buy | 9,750 | — | — |
| 2025-01-31 | HAMMOND, JANET MJ | Chief Development Officer | Buy | 200,000 | — | — |
| 2025-01-31 | HAMMOND, JANET MJ | Chief Development Officer | Sale | 46,800 | — | — |
| 2025-01-31 | HAMMOND, JANET MJ | Chief Development Officer | Buy | 11,250 | — | — |
| 2025-01-31 | HAMMOND, JANET MJ | Chief Development Officer | Buy | 46,800 | — | — |
| 2025-01-31 | HAMMOND, JANET MJ | Chief Development Officer | Sale | 14,134 | $3.06 | $43250.04 |
| 2025-01-31 | HAMMOND, JANET MJ | Chief Development Officer | Buy | 11,250 | — | — |
| 2025-01-31 | FOSTER, WAYNE | EVP, Chief Accounting Officer | Buy | 120,100 | — | — |
| 2025-01-31 | FOSTER, WAYNE | EVP, Chief Accounting Officer | Sale | 33,333 | — | — |
| 2025-01-31 | FOSTER, WAYNE | EVP, Chief Accounting Officer | Buy | 8,000 | — | — |
| 2025-01-31 | FOSTER, WAYNE | EVP, Chief Accounting Officer | Buy | 33,333 | — | — |
| 2025-01-31 | FOSTER, WAYNE | EVP, Chief Accounting Officer | Sale | 12,062 | $3.06 | $36909.72 |
| 2025-01-31 | FOSTER, WAYNE | EVP, Chief Accounting Officer | Buy | 8,000 | — | — |
| 2025-01-31 | CORCORAN, ANDREA | See Remarks | Buy | 200,000 | — | — |
| 2025-01-31 | CORCORAN, ANDREA | See Remarks | Sale | 44,367 | — | — |
| 2025-01-31 | CORCORAN, ANDREA | See Remarks | Buy | 10,500 | — | — |
| 2025-01-31 | CORCORAN, ANDREA | See Remarks | Buy | 44,367 | — | — |
| 2025-01-31 | CORCORAN, ANDREA | See Remarks | Sale | 16,102 | $3.06 | $49272.12 |
| 2025-01-31 | CORCORAN, ANDREA | See Remarks | Buy | 10,500 | — | — |
| 2025-01-16 | BERGER, FRANKLIN M | Director | Buy | 10,000 | $3.36 | $33614.00 |
| 2025-01-15 | BERGER, FRANKLIN M | Director | Buy | 15,000 | $3.19 | $47884.50 |
| 2024-12-10 | BERGER, FRANKLIN M | Director | Sale | 359,606 | $2.85 | $1.02M |
| 2024-09-19 | SOMMADOSSI, JEAN-PIERRE | Director, President, CEO, and Chairman | Sale | 1,841 | $4.00 | $7367.50 |
| 2024-09-18 | SOMMADOSSI, JEAN-PIERRE | Director, President, CEO, and Chairman | Sale | 22,187 | $4.03 | $89469.08 |
| 2024-09-17 | SOMMADOSSI, JEAN-PIERRE | Director, President, CEO, and Chairman | Sale | 33,941 | $4.05 | $137318.50 |
| 2024-06-21 | POLSKY, BRUCE | Director | Buy | 41,200 | — | — |
| 2024-06-21 | POLSKY, BRUCE | Director | Buy | 29,600 | — | — |
| 2024-06-21 | MURPHY, POLLY A. | Director | Buy | 41,200 | — | — |
| 2024-06-21 | MURPHY, POLLY A. | Director | Buy | 29,600 | — | — |
| 2024-06-21 | LUCIDI, BRUNO | Director | Buy | 41,200 | — | — |
Frequently asked questions
Are AVIR insiders buying or selling?
Over the transactions on record, AVIR insiders have been net buyers, with about $2.49M in stock sold across 41 sales, against 4 open-market purchases.
Does insider selling at AVIR mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which AVIR insiders are selling the most?
Recent selling is concentrated in a few names. BERGER, FRANKLIN M accounts for the largest share on record, with about $1.02M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.